Clinical Trials Logo

Masseter Muscle Hypertrophy clinical trials

View clinical trials related to Masseter Muscle Hypertrophy.

Filter by:
  • None
  • Page 1

NCT ID: NCT06408766 Not yet recruiting - Clinical trials for Smartphone Addiction

Investigating the Effects of Smartphone Use on the Masseter Muscle

Start date: May 30, 2024
Phase:
Study type: Observational

The aim of this study was to determine the short- and long-term effects of smartphone use on the masseter muscle. In the short term, to investigate whether repetitive thumb movements during phone use will cause a spontaneous muscle activation and/or tenderness in the masseter muscle; in the long term, to investigate the relationship between strength change and tenderness of the tenar and masseter muscles depending on the intensity and duration of phone use.

NCT ID: NCT06343194 Recruiting - Sleep Bruxism Clinical Trials

Changes in Electromyographic Activity in Aligner Treatment of Adult Patients With and Without Nocturnal Bruxism

EMG_BRUX
Start date: February 9, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effectiveness of clear aligners on the symptoms and signs reported by bruxism patients. The aim of the investigators is to evaluate the effect of treatment on the masticatory muscles and the changes related to the tropism of the masseter muscles using Bruxoff ® device, before and after the beginning of the therapy. Bruxoff ® is a holter that assesses the contractions of the masseter muscles and the heart during sleep. The plan is to compare treatment with clear aligners for bruxism and non-bruxism patients. The results will allow the investigators to evaluate the progress of clear aligner therapy in bruxism patients and compare them with those of non-bruxism patients.

NCT ID: NCT03452345 Completed - Clinical trials for Masseter Muscle Hypertrophy

MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy

Start date: April 9, 2018
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of MEDITOXIN in subjects with benign masseteric hypertrophy compared with placebo

NCT ID: NCT03376464 Completed - Clinical trials for Masseter Muscle Hypertrophy

Xeomin Cosmetic in the Management of Masseter

Start date: November 6, 2015
Phase: Phase 4
Study type: Interventional

The goal of this study was to evaluate the efficacy and safety of two injection techniques in the management of masseteric hypertrophy using Xeomin Cosmetic.

NCT ID: NCT02010775 Completed - Clinical trials for Masseter Muscle Hypertrophy

Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy

Start date: January 20, 2014
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of a range of doses of botulinum toxin Type A (BOTOX®) for the treatment of patients with bilateral Masseter Muscle Hypertrophy (MMH).